American Journal of Clinical Pathology · 1991 · 82 citations · 17 references
Maternal ImmunizationAbortionPathogenesisImmunologyLantern CellsPathologyVirologyGynecologyParvovirus B19 InfectionFetal MedicineVirus ClassificationFetal TissuesMaternal-fetal MedicineFetal ComplicationMedicineB19 InfectionPlacental ImmunologyViral Genetics
Fetal tissues from 16 spontaneous abortions, two terminations, and one perinatal death, 18 of which were associated with maternal human parvovirus B19 infection, were examined for B19 infection by histology and in situ hybridization using a digoxigenin-labeled B19-DNA probe. In 15 spontaneous abortions and one termination, erythroblasts with intranuclear inclusions (lantern cells) reacted with B19-DNA by in situ hybridization. No internal or external fetal malformations were observed. Because 13 (86.7%) spontaneous abortions with lantern cells occurred between the 20th and 28th weeks of gestation, it is postulated that B19 infection may be a particular threat to the fetus during this stage of gestation.
17
Su-Ming Hsu, Laurence Raine, Herbert Fanger · American Journal of Clinical Pathology · 1981 · 1.7K citations
Immunohematology, Peroxidase-antiperoxidase Method, Immunocytochemical Technique +18
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERA
Yvonne E. Cossart, Barbara Cant, A. M. Field et al. · The Lancet · 1975 · 957 citations
Serologically proved intrauterine infection with parvovirus.
P. Daniel Knott, G A Welply, M. J. Anderson · BMJ · 1984 · 161 citations · Full text